Upcoming Revenue of Cancer Supportive Care Products: Lung Cancer to Become Second Largest Disease Indication by 2021

Press Release – 09 Jan 2019

Research and Development News --

. .

Latest Update "Global Market Study on Cancer Supportive Care Products: Lung Cancer to Become Second Largest Disease Indication by 2021" with Industries Survey | Global Current Growth and Future.

' '

An up-to-date business publication by Persistence Market Research notifies that the shares in the global cancer supportive care products market is consolidated among a handful of players. There are only a few companies that can be ascribed as market leaders whereas the competition is much stiff among mid-level and emerging players. Hoffman LA-Roche, Novartis AG, Amgen, Baxter, and Teva Pharmaceuticals are a few notable names in the market for cancer supportive care products.

Most of these players are enhancing their business operations in international markets by launching new products. In addition to this, making equity investments in companies that have the potential to devise niche technologies, expanding into emerging economies to tap new customers, and indulging in mergers and acquisitions are some of the other strategies frequently adopted by these players.

. .

– Get Sample Report_ https://www.researchmoz.us/enquiry.php?type=S&repid=1834469

' '

“Global Cancer Supportive Care Products Market to be Worth US$ 31,700.0 Mn by 2021”

As the PMR report foresees the future of the cancer supportive care products market, the demand will expand at a notable CAGR of 4.8% during the forecast period of 2017 to 2021. In terms of revenue, the concerned market is poised to attain a valuation of US$ 31,700.0 Mn by the end of 2021, considerably more than its evaluated 2017 worth of US$ 26,285.5 Mn in 2017.

On the basis of drug class, the report segments the market for cancer supportive care products into nonsteroidal erythropoietin stimulating agents, opioid analgesics, anti-imflammatory drugs, anti-infective drugs, bisphosphonates, anti-emetics drugs, monoclonal antibodies, and granulocyte colony stimulating factor. Indication-wise, the market has been bifurcated into lung cancer, prostate cancer, breast cancer, leukemia, ovarian cancer, bladder cancer, liver cancer, melanoma, and others. 

This report on the cancer supportive care products market analyzes the current and future scenario of the global demand and provides evaluations as well as estimations for the forecast period of 2017 to 2021. The report has been prepared by experienced and professional research analysts and aspires to serve as a credible business tool for its targeted audiences such as academic research institutes, drug manufacturers and suppliers, hospitals and clinics, research and development (R&D) companies, medical research laboratories, and academic medical centers and universities.

. .

– For Other Requirement and Enquiry_ https://www.researchmoz.us/enquiry.php?type=E&repid=1834469

' '

“Segmentation”

On the basis of drug class, the report segments the cancer supportive care products market into nonsteroidal erythropoietin stimulating agents, opioid analgesics, anti-imflammatory drugs, anti-infective drugs, bisphosphonates, anti-emetics drugs, monoclonal antibodies, and granulocyte colony stimulating factor. Indication-wise, the market has been bifurcated into lung cancer, prostate cancer, breast cancer, ovarian cancer, leukemia, bladder cancer, liver cancer, melanoma, and others. Based on distribution channel, the market has been classified into hospital pharmacies, compounding pharmacies, and retail pharmacies. Geographically, the report evaluates the potential of demand that can be expected out of the regions of Asia Pacific, North America, Latin America, the Middle East and Africa (MEA), and Europe.

“Erythropoietin Stimulating Agents In-demand Drug-class Segment”

Based on drug class, this report segments the market for cancer supportive care products into opioid analgesics, nonsteroidal erythropoietin stimulating agents, anti-infective drugs, anti-imflammatory drugs, bisphosphonates, monoclonal antibodies, anti-emetics drugs, and granulocyte colony stimulating factor. Among these, the segments of erythropoietin stimulating agents and granulocyte colony stimulating factor are projected to provide for the maximum chunk of demand at 25.0% and 20.2% respectively by the end of 2021.

“Lung and Breast Cancer Providing for the Maximum Demand”

Indication-wise, the cancer supportive care products market has been bifurcated into lung cancer, prostate cancer, breast cancer, ovarian cancer, leukemia, bladder cancer, liver cancer, melanoma, and others. By the end of the year 2021, the others segment is poised to be most profitable, but that will be distributed among various types of cancer. Individually, lung cancer and breast cancer are the two key segments, primed to provide for a demand percentage of 14.8% and 13.6% respectively by 2021. Initiatives by several governments to increase awareness regarding lung and breast cancer is expected to drive growth of these two segments. On the basis of distribution channel, the report segments the market into hospital pharmacies, compounding pharmacies, and retail pharmacies.

Continue.....

– More Clear Details get Full Table of Contents_ https://www.researchmoz.us/global-market-study-on-cancer-supportive-care-products-lung-cancer-to-become-second-largest-disease-indication-by-2021-report.html/toc

About Researchmoz,

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

--Researchmoz Global Pvt. Ltd.--

Mr. Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us